desloratadine cipla tablet, film coated 5mg
cipla europe n.v. uitbreidingstraat 80, 2600 antwerp, belgium - desloratadine - film-coated tablet - desloratadine 5 mg - antihistamines for systemic use
synerrv desloratadine 5 (desloratadine tablets 5mg)
synerrv sdn bhd - desloratadine -
loratadine- loratadine tablet
camber consumer care inc - loratadine (unii: 7ajo3bo7qn) (loratadine - unii:7ajo3bo7qn) - antihistamine temporarily relieves these symptoms due to hay fever or other upper respiratory allergies: - runny nose - itchy, watery eyes - sneezing - itching of the nose or throat if you have ever had an allergic reaction to this product or any of its ingredients. liver or kidney disease. your doctor should determine if you need a different dose. an allergic reaction to this product occurs. seek medical help right away.
loratadine d- loratadine, pseudoephedrine sulfate tablet, film coated, extended release
padagis israel pharmaceuticals ltd - loratadine (unii: 7ajo3bo7qn) (loratadine - unii:7ajo3bo7qn), pseudoephedrine sulfate (unii: y9dl7qpe6b) (pseudoephedrine - unii:7cuc9ddi9f) - antihistamine nasal decongestant
loratadine d- loratadine, pseudoephedrine tablet, extended release
perrigo new york inc - loratadine (unii: 7ajo3bo7qn) (loratadine - unii:7ajo3bo7qn), pseudoephedrine sulfate (unii: y9dl7qpe6b) (pseudoephedrine - unii:7cuc9ddi9f) - antihistamine nasal decongestant
loratadine d- loratadine, pseudoephedrine tablet, extended release
bryant ranch prepack - loratadine (unii: 7ajo3bo7qn) (loratadine - unii:7ajo3bo7qn), pseudoephedrine sulfate (unii: y9dl7qpe6b) (pseudoephedrine - unii:7cuc9ddi9f) - antihistamine nasal decongestant
clarinex-d 12 hour- desloratadine and pseudoephedrine sulfate tablet, extended release
physicians total care, inc. - desloratadine (unii: fvf865388r) (desloratadine - unii:fvf865388r), pseudoephedrine sulfate (unii: y9dl7qpe6b) (pseudoephedrine - unii:7cuc9ddi9f) - desloratadine 2.5 mg - clarinex-d® 12 hour extended release tablets is indicated for the relief of the nasal and non-nasal symptoms of seasonal allergic rhinitis, including nasal congestion, in adults and adolescents 12 years of age and older. clarinex-d 12 hour extended release tablets should be administered when the antihistaminic properties of desloratadine and the nasal decongestant properties of pseudoephedrine are desired [see clinical pharmacology (12)] . clarinex-d 12 hour extended release tablets are contraindicated in: - patients with hypersensitivity to any of its ingredients, or to loratadine [see warnings and precautions (5.4) and post-marketing experience (6.2)] - patients with narrow angle glaucoma - patients with urinary retention - patients receiving monoamine oxidase (mao) inhibitor therapy or within fourteen (14) days of stopping such treatment [see drug interactions (7.1)] . - patients with severe hypertension or severe coronary artery disease pregnancy category c: there are no adequate and well-controlled stu
clarinex-d 12 hour- desloratadine and pseudoephedrine sulfate tablet, extended release
merck sharp & dohme corp. - desloratadine (unii: fvf865388r) (desloratadine - unii:fvf865388r), pseudoephedrine sulfate (unii: y9dl7qpe6b) (pseudoephedrine - unii:7cuc9ddi9f) - desloratadine 2.5 mg - clarinex-d® 12 hour extended release tablets is indicated for the relief of the nasal and non-nasal symptoms of seasonal allergic rhinitis, including nasal congestion, in adults and adolescents 12 years of age and older. clarinex-d 12 hour extended release tablets should be administered when the antihistaminic properties of desloratadine and the nasal decongestant properties of pseudoephedrine are desired [see clinical pharmacology (12)]. clarinex-d 12 hour extended release tablets are contraindicated in: - patients with hypersensitivity to any of its ingredients, or to loratadine [see warnings and precautions (5.4) and adverse reactions (6.2)] - patients with narrow-angle glaucoma - patients with urinary retention - patients receiving monoamine oxidase (mao) inhibitor therapy or within fourteen (14) days of stopping such treatment [see drug interactions (7.1)] - patients with severe hypertension or severe coronary artery disease risk summary the limited available data with clarinex-d 12 hour in pregnant wom
loratadine- loratadine tablet
kaiser foundation hospitals - loratadine (unii: 7ajo3bo7qn) (loratadine - unii:7ajo3bo7qn) - antihistamine temporarily relieves these symptoms due to hay fever or other upper respiratory allergies: - runny nose - itchy, watery eyes - sneezing - itching of the nose or throat
loratadine- loratadine tablet
healthmart - loratadine (unii: 7ajo3bo7qn) (loratadine - unii:7ajo3bo7qn) - antihistamine temporarily relieves these symptoms due to hay fever or other upper respiratory allergies: